GetHealthyCalculators
Skip to content

Peptide Dose Reference Guide

This tool is a reference guide to doses used in published scientific research for common research peptides and peptide-based medications. It is strictly educational. The doses listed reflect what was studied in specific research contexts — they are not recommendations, prescriptions, or suggestions for personal use. For peptides without FDA approval, human equivalent dosing may not be established. For FDA-approved medications such as semaglutide, approved doses are from prescribing information and clinical trial data. Always consult a licensed healthcare provider for any medical decision.

Reviewed by GetHealthyCalculators Editorial Team · Updated April 11, 2026

Quick Answer

Doses shown are from published research studies only and are presented as educational reference. They are not recommendations for personal use. Study context (animal vs. human, sample size, endpoints) is noted for each peptide.

These results are estimates based on general formulas and are not a substitute for professional medical advice. Consult a healthcare provider before making health decisions.

Educational Reference Only

Doses shown are from published research studies only. This is not a recommendation for personal use. Always consult a licensed healthcare provider before using any compound.

Select a peptide above to view the doses used in published research studies.

How the Formula Works

  1. Select a peptide from the list. The tool retrieves the dose range used in the most commonly cited research for that compound.

    Input: peptide selection
  2. Review the dose range, unit, frequency, and study citation. Note whether the data comes from animal or human studies.

    Output: study dose range, context, citation
  3. Review the human equivalence note, which explains whether the dose has been tested in humans or extrapolated from animal models.

    Human equivalence: established (human trial) or not established (animal only)

Methodology & Sources

Reviewed and updated April 11, 2026 · Prepared by GetHealthyCalculators Editorial Team

Dose data is sourced from the primary research citations listed for each peptide. No extrapolation or interpretation beyond the published data is applied. Semaglutide doses reflect FDA-approved prescribing information from the SUSTAIN (Ozempic) and STEP (Wegovy) trial programs.

Limitations

  • This reference is strictly educational. No dose shown should be interpreted as a recommendation for personal use.
  • Animal study doses are not validated for human use. Human equivalence may not be established.
  • Peptides without FDA approval are unregulated research chemicals in most jurisdictions. Their safety and purity as commercially available products may not match research-grade compounds.
  • This tool does not link to vendors, compounding pharmacies, or any source for obtaining peptides.
  • Legal status of research peptides varies by country. Users are responsible for understanding the regulations in their jurisdiction.
  • Published research doses reflect specific study designs, populations, endpoints, and durations — context matters and cannot be fully captured in a single dose number.

Frequently Asked Questions

Are these doses recommendations?
No. All doses listed are what was used in the specific published study cited for each peptide. They are presented for educational reference only. This tool does not recommend, prescribe, or advise any dose for any individual. Consult a licensed healthcare provider for personal medical guidance.
What does "doses used in research studies" mean?
It means that in a specific published scientific study, researchers administered those doses to their study subjects — either animals or humans — and measured an outcome. The dose is not a validated safe or effective dose for general use; it is what was studied.
Why is semaglutide listed alongside research peptides?
Semaglutide is an FDA-approved GLP-1 receptor agonist with well-documented human dosing from clinical trials and prescribing information. It is included because it is a peptide-based drug frequently researched alongside other peptides. Its doses differ importantly from non-approved compounds — they are validated by large Phase III human trials.
Is BPC-157 legal?
BPC-157 is not FDA-approved for human use. As of 2023, the FDA issued guidance that BPC-157 may not be used in compounded preparations. Its legal status varies by country. This guide does not link to any source for obtaining BPC-157.
Why do animal studies matter if they cannot be directly applied to humans?
Animal studies are an important step in pharmacological research. They help identify potential mechanisms of action, dose ranges for safety testing, and hypotheses for future human trials. However, results from animal models frequently do not translate directly to humans due to differences in physiology, metabolism, and pharmacokinetics.
What is the difference between animal and human study context?
Human equivalence means a dose was tested in human clinical trials and showed a measurable effect. Animal context means the dose was tested in rodents, dogs, or other non-human species. Human equivalent doses from animal studies can be estimated using body surface area scaling, but this scaling is approximate and not validated for most peptides.

If you are on a GLP-1, estimate your muscle loss risk

GLP-1 Muscle Loss Risk Calculator

More on This Topic